Publications by authors named "Janice Rusnak"

Claim this Profile
S
Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Betty Mwesigwa, Fredrick Sawe, Janet Oyieko, Joel Mwakisisile, Edna Viegas, Janice Rusnak

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial.
Julie A Ake, Kristopher Paolino, Jack N Hutter, Susan Biggs Cicatelli, Leigh Anne Eller, Janice Rusnak

Vaccines (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
David K Clarke, Rong Xu, Demetrius Matassov, Theresa E Latham, Ayuko Ota-Setlik, Janice M Rusnak

Lancet Infect Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.
Nicholas J Machesky, Janice M Rusnak, Evan H Moore, Christopher B Dorsey, Lucy A Ward

Toxicon· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule.
Janice M Rusnak, Pamela J Glass, Scott C Weaver, Carol L Sabourin, Andrew M Glenn

Viruses· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.
Janice M Rusnak, Lesley C Dupuy, Nancy A Niemuth, Andrew M Glenn, Lucy A Ward

Comp Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.
Nicholas G Conger, Kristopher M Paolino, Erik C Osborn, Janice M Rusnak, Stephan Günther

Emerg Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
Ellen F Boudreau, Matthew Josleyn, Diane Ullman, Diana Fisher, Lonnie Dalrymple, Janice Rusnak

Vaccine· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
Janice M Rusnak, Paul Gibbs, Ellen Boudreau, Denise P Clizbe, Phillip Pittman

Vaccine· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum neurotoxin vaccines: Past history and recent developments.
Janice M Rusnak, Leonard A Smith

Hum Vaccin· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.
Janice M Rusnak, William R Byrne, Kyung N Chung, Paul H Gibbs, Theodore T Kim

Antiviral Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit.
Mark G Kortepeter, James W Martin, Janice M Rusnak, Theodore J Cieslak, Kelly L Warfield

Emerg Infect Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum neurotoxin vaccines: past, present, and future.
Leonard A Smith, Janice M Rusnak

Crit Rev Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
Zygmunt F Dembek, Leonard A Smith, Janice M Rusnak

Disaster Med Public Health Prep· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaction after smallpox vaccination.
John W Aldis, Mark G Kortepeter, Janice M Rusnak

Am Fam Physician· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers.
Janice M Rusnak, Mark G Kortepeter, Robert J Hawley, Arthur O Anderson, Ellen Boudreau

Biosecur Bioterror· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of U.S. military contributions to the study of parasitic diseases.
Nancy F Crum, Naomi E Aronson, Edith R Lederman, Janice M Rusnak, John H Cross

Mil Med· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory exposures to staphylococcal enterotoxin B.
Janice M Rusnak, Mark Kortepeter, Robert Ulrich, Mark Poli, Ellen Boudreau

Emerg Infect Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management guidelines for laboratory exposures to agents of bioterrorism.
Janice M Rusnak, Mark G Kortepeter, Robert J Hawley, Ellen Boudreau, John Aldis

J Occup Environ Med· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).
Janice M Rusnak, Mark G Kortepeter, John Aldis, Ellen Boudreau

J Occup Environ Med· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual inhalational exposure to Bacillus anthracis in a research laboratory.
Janice Rusnak, Ellen Boudreau, Joel Bozue, Patricia Petitt, Manmohan Ranadive

J Occup Environ Med· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCRBV CDR3 diversity of CD4+ and CD8+ T-lymphocytes in HIV-infected individuals.
Frank M Raaphorst, Robert L Schelonka, Janice Rusnak, Anthony J Infante, Judy M Teale

Hum Immunol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis